PT IMC Pelita Logistik Tbk (IDX:PSSI)

Sage Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	67.41	81.21	102.39	119.28	108.73	68.36
Revenue Growth (YoY)	-26.61%	-20.69%	-14.16%	9.70%	59.07%	-9.25%
Cost of Revenue	56.99	59.97	64.67	75.95	73.83	55.88
Gross Profit	10.42	21.23	37.72	43.33	34.9	12.48
Selling, General & Admin	6.09	6.63	8.19	6.42	4.73	4.58
Other Operating Expenses	-0.71	-0.85	-0.79	-0.62	1.04	0.57
Operating Expenses	5.98	6.31	7.93	6.24	6.22	5.59
Operating Income	4.44	14.92	29.79	37.09	28.68	6.89
Interest Expense	-2.02	-1.61	-1.54	-1.25	-1.14	-1.58
Interest & Investment Income	2.55	3.29	1.27	0.3	0.04	0.06
Currency Exchange Gain (Loss)	2.55	-2.07	0.37	-1.69	0.08	-0.28
Other Non Operating Income (Expenses)	0.54	-0.48	0.05	0.15	0.73	2.53
EBT Excluding Unusual Items	8.06	14.05	29.94	34.61	28.39	7.61
Gain (Loss) on Sale of Assets	1.48	3.16	16.79	11.27	0.21	0
Pretax Income	9.53	17.2	46.73	47.77	28.66	7.66
Income Tax Expense	3.02	2.88	5.84	5.44	3.62	-0.77
Earnings From Continuing Operations	6.52	14.32	40.89	42.33	25.04	8.43
Minority Interest in Earnings	-0.08	-0.13	-0.1	-0.13	-0.02	-
Net Income	6.43	14.19	40.79	42.2	25.02	8.43
Net Income to Common	6.43	14.19	40.79	42.2	25.02	8.43
Net Income Growth	-67.92%	-65.22%	-3.35%	68.69%	196.77%	-36.56%
Shares Outstanding (Basic)	5,236	5,237	5,227	5,255	5,396	5,417
Shares Outstanding (Diluted)	5,236	5,237	5,326	5,255	5,396	5,417
Shares Change (YoY)	-2.52%	-1.67%	1.35%	-2.61%	-0.39%	5.81%
EPS (Basic)	0.00	0.00	0.01	0.01	0.00	0.00
EPS (Diluted)	0.00	0.00	0.01	0.01	0.00	0.00
EPS Growth	-68.98%	-64.47%	-5.38%	73.23%	197.94%	-40.04%
Free Cash Flow	11.4	13.63	19.11	9.83	25.57	16.19
Free Cash Flow Per Share	0.00	0.00	0.00	0.00	0.01	0.00
Dividend Per Share	0.001	0.002	0.003	0.003	0.002	0.001
Dividend Growth	-89.17%	-28.19%	-3.29%	63.87%	110.61%	-
Gross Margin	15.46%	26.15%	36.84%	36.33%	32.10%	18.25%
Operating Margin	6.58%	18.38%	29.10%	31.10%	26.38%	10.07%
Profit Margin	9.54%	17.47%	39.84%	35.38%	23.01%	12.33%
Free Cash Flow Margin	16.91%	16.78%	18.67%	8.24%	23.52%	23.68%
EBITDA	12.85	25.93	39.51	45.43	36.68	17.34
EBITDA Margin	19.06%	31.93%	38.58%	38.09%	33.73%	25.37%
D&A For EBITDA	8.41	11	9.71	8.34	8	10.45
EBIT	4.44	14.92	29.79	37.09	28.68	6.89
EBIT Margin	6.58%	18.38%	29.10%	31.10%	26.38%	10.07%
Effective Tax Rate	31.66%	16.75%	12.50%	11.38%	12.64%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.